繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

PolyPid任命Nurit Tweezer-Zaks为首席医疗官

2025-08-12 21:05

  • PolyPid  (NASDAQ:PYPD) announced on Tuesday the appointment of Dr. Nurit Tweezer-Zaks as chief medical officer, effective as of August 18, 2025.
  • Tweezer-Zaks, who has served on PolyPid's board of directors, since November 2023, will step down from the Board, effective as of August 17, 2025.
  • Prior to joining PolyPid, she served as chief executive officer of MediCane Health. 
  • PYPD -0.0% premarket to $3.23
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。